Synthetic cannabinoid-induced mood disorder

Synthetic cannabinoid-induced mood disorder is characterized by mood symptoms (e.g., depressed or elevated mood, decreased engagement in pleasurable activities, increased or decreased energy levels) that develop during or soon after intoxication with or withdrawal from synthetic cannabinoids. The intensity or duration of the symptoms is substantially in excess of mood disturbances that are characteristic of Synthetic cannabinoid intoxication or Synthetic cannabinoid withdrawal. The amount and duration of synthetic cannabinoid use must be capable of producing mood symptoms. The symptoms are not better explained by a primary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if the mood symptoms preceded the onset of the synthetic cannabinoid use, if the symptoms persist for a substantial period of time after cessation of the synthetic cannabinoid use or withdrawal, or if there is other evidence of a pre-existing primary mental disorder with mood symptoms (e.g., a history of prior episodes not associated with synthetic cannabinoid use).

ICD-11 diagnostic criteria

• obniżony lub podwyższony nastrój
• związek z używaniem substancji

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Synthetic cannabinoid-induced mood disorder are:

• obniżony nastrój

Differential diagnosis

When diagnosing Synthetic cannabinoid-induced mood disorder, the following ICD-11 disorders should be considered in the differential diagnosis:

• Zaburzenia związane z używaniem kannabinoidów pochodzenia roślinnego (6C41)

Frequently asked questions

How is Synthetic cannabinoid-induced mood disorder diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Synthetic cannabinoid-induced mood disorder (6C42.70) include: obniżony lub podwyższony nastrój; związek z używaniem substancji.

What disorders are in the differential diagnosis of Synthetic cannabinoid-induced mood disorder?

The differential diagnosis of Synthetic cannabinoid-induced mood disorder (6C42.70) includes: Zaburzenia związane z używaniem kannabinoidów pochodzenia roślinnego (6C41).

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C42.70 – WHO ICD-11

Notes

Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną